Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109503547B reveals a green S8-based route for high-purity benzodithiolanes, offering cost-effective manufacturing solutions.
Patent CN110015999B reveals a one-pot, acid-catalyzed route to 1,2,3-triazoles, eliminating metal catalysts for high-purity pharmaceutical intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply chains and cost-effective manufacturing.
Novel palladium catalyzed synthesis offers high yield arylamine derivatives. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yields, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced metabolic stability.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective pharmaceutical intermediate manufacturing.
Patent CN109096186B reveals a green ultrasound-assisted aqueous synthesis for 2-arylsulfonyl quinolines, offering significant cost reduction in API manufacturing and superior purity.
Patent CN113105402B details a metal-free iodine-promoted synthesis of trifluoromethyl triazoles, offering significant cost reduction and simplified supply chains for API manufacturing.
Patent CN111253293B reveals efficient iron-catalyzed synthesis. Delivers high-purity intermediates with significant cost reduction in pharmaceutical manufacturing.
Patent CN112239436A details a safe, one-step synthesis of bioactive furanones using solid CO sources, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108623496B reveals a safe, scalable route for 3-ethyl-4-fluorobenzonitrile, eliminating toxic tin reagents for cost-effective API manufacturing.
Patent CN113549062A discloses bulky chiral quaternary ammonium salts enhancing enantioselectivity in KMnO4 oxidation, offering cost-effective API intermediate solutions.
Patent CN111675662B reveals a novel FeCl3-catalyzed cyclization for 2-trifluoromethyl quinazolinones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable production.
Novel Pd-catalyzed carbonylation method using solid CO source offers safe, scalable production of high-purity pharmaceutical intermediates with broad substrate tolerance.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API intermediates.
Patent CN111217693A details a cuprous halide catalyzed carboxylation method using CO2, offering cost-effective routes for high-purity pharmaceutical intermediates and fine chemicals.
Patent CN109942387A details a copper catalyzed method for cyclopropane derivatives offering high yield and cost reduction for pharmaceutical intermediate manufacturing.